About: Hildegard Greinix

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Hildegard Greinix Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher

Attributes	Values
rdf:type	Item
description	Forscher (de) forskare (sv) ikertzailea (eu) researcher (en) investigador (es) chercheur (fr) дослідниця (uk) изилдөөчү (ky) 研究者 (zh) 研究員 (ja) onderzoeker (nl)
rdfs:label	Hildegard Greinix (en) Hildegard Greinix (es) Hildegard Greinix (fr) Hildegard Greinix (nl) Hildegard Greinix (ast)
skos:prefLabel	Hildegard Greinix (en) Hildegard Greinix (es) Hildegard Greinix (fr) Hildegard Greinix (nl) Hildegard Greinix (ast)
name	Hildegard Greinix (en) Hildegard Greinix (es) Hildegard Greinix (fr) Hildegard Greinix (nl) Hildegard Greinix (ast)
given name	wds:Q47158589-F6807530-FE3D-4877-999E-84880E3B042D
given name	Hildegard
instance of	wds:Q47158589-C90C7D85-7DA9-43DA-B725-444AE27D99E0
instance of	Homo sapiens
occupation	wds:Q47158589-E6AE904C-81F1-49C2-ACAD-04383751C63A
employer	wds:Q47158589-D1A05D2B-72A8-41A3-A50B-9953909732B7
sex or gender	wds:Q47158589-51332975-9EEC-4DDA-A803-C48FDEA9E278
ISNI	wds:Q47158589-B48410A4-CD5E-4AA6-8DB4-6AE0A6DC51A4
VIAF ID	wds:Q47158589-D7AA2DB8-B482-4D0A-8113-7A8785602590
Library of Congress authority ID	wds:Q47158589-CFC1EE59-BFE9-4558-8AE2-02731A811A03
WorldCat Identities ID (superseded)	wds:Q47158589-F7A523B2-B180-4A5E-A279-3DBCDDFF1962
National Library of Israel J9U ID	wds:Q47158589-B6257AE5-843C-4D2A-AD29-4C6640B8B3B9
VIAF ID	http://viaf.org/viaf/81214062
Library of Congress authority ID	http://id.loc.gov/authorities/names/n2010184107
occupation	researcher
employer	Medical University of Graz
sex or gender	female organism
ISNI	0000000090832329
VIAF ID	81214062
Library of Congress authority ID	n2010184107
WorldCat Identities ID (superseded)	lccn-n2010184107
National Library of Israel J9U ID	987007353056705171
ORCID iD	wds:Q47158589-88B17BA0-7A8D-4F4C-8C6A-0EE12DF43F82
ORCID iD	https://orcid.org/0000-0002-2780-3300
ORCID iD	0000-0002-2780-3300
is owl:sameAs of	Hildegard Greinix
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q47158589
is author of	Extracorporeal photopheresis: past, present, and future Allogeneic stem-cell transplantation in patients with Waldenström macroglobulinemia: report from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation Extracorporeal photopheresis as second-line treatment for acute graft-versus-host disease: impact on six-month freedom from treatment failure Extracorporeal photopheresis versus anticytokine therapy as a second-line treatment for steroid-refractory acute GVHD: a multicenter comparative analysis. Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report. Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the German-Austrian-Swiss Consensus Conference on Clinical Practice in chronic GVHD. Severe events in donors after allogeneic hematopoietic stem cell donation One million haemopoietic stem-cell transplants: a retrospective observational study Diverse T-cell responses characterize the different manifestations of cutaneous graft-versus-host disease Autologous/reduced-intensity allogeneic stem cell transplantation vs autologous transplantation in multiple myeloma: long-term results of the EBMT-NMAM2000 study. Tandem autologous/reduced-intensity conditioning allogeneic stem-cell transplantation versus autologous transplantation in myeloma: long-term follow-up Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease Prognostic significance of NOD2/CARD15 variants in HLA-identical sibling hematopoietic stem cell transplantation: effect on long-term outcome is confirmed in 2 independent cohorts and may be modulated by the type of gastrointestinal decontamination Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease Autologous stem cell transplantation for systemic lupus erythematosus Results of genoidentical hemopoietic stem cell transplantation with reduced intensity conditioning for acute myelocytic leukemia: higher doses of stem cells infused benefit patients receiving transplants in second remission or beyond--the Acute Leuk Oral chronic graft-versus-host disease: report from the International Consensus Conference on clinical practice in cGVHD. Vaccination of allogeneic haematopoietic stem cell transplant recipients: report from the international consensus conference on clinical practice in chronic GVHD. Low p27Kip1 expression is an independent adverse prognostic factor in patients with multiple myeloma. Mobilized peripheral blood stem cells compared with bone marrow as the stem cell source for unrelated donor allogeneic transplantation with reduced-intensity conditioning in patients with acute myeloid leukemia in complete remission: an analysis fro Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+ cell selection: long term follow-up of an EBMT phase III randomized study. Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation Repeated fecal microbiota transplantations attenuate diarrhea and lead to sustained changes in the fecal microbiota in acute, refractory gastrointestinal graft-versus-host-disease Regulation of advanced therapy medicinal products in Europe and the role of academia Validation of the human activity profile questionnaire in patients after allogeneic hematopoietic stem cell transplantation. Skin explant model of human graft-versus-host disease: prediction of clinical outcome and correlation with biological risk factors. Removal of persisting isohaemagglutinins with Ig-Therasorb(R) immunoadsorption after major ABO-incompatible non-myeloablative allogeneic haematopoietic stem cell transplantation Long-term follow-up after allogeneic stem cell transplantation Quantitative comparison of the expression of EVI1 and its presumptive antagonist, MDS1/EVI1, in patients with myeloid leukemia Adiponectin and resistin in acute and chronic graft-vs-host disease patients undergoing allogeneic hematopoietic stem cell transplantation Rapid establishment of long-term culture-initiating cells of donor origin after nonmyeloablative allogeneic hematopoietic stem-cell transplantation, and significant prognostic impact of donor T-cell chimerism on stable engraftment and progression-fr Consensus on the histopathological evaluation of liver biopsies from patients following allogeneic hematopoietic cell transplantation Epidermal elafin expression is an indicator of poor prognosis in cutaneous graft-versus-host disease The treatment of chronic graft-versus-host disease: consensus recommendations of experts from Germany, Austria, and Switzerland Incidence and characteristics of invasive fungal diseases in allogeneic hematopoietic stem cell transplant recipients: a retrospective cohort study Milestones of Hematopoietic Stem Cell Transplantation - From First Human Studies to Current Developments The eGVHD App has the potential to improve the accuracy of graft-versus-host disease assessment: a multicenter randomized controlled trial "Worldwide Network for Blood & Marrow Transplantation (WBMT) special article, challenges facing emerging alternate donor registries" Association of uric acid levels before start of conditioning with mortality after alloSCT: a prospective, non-interventional study of the EBMT Transplant Complication Working Party Correction: Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countries Impact of Donor Epstein-Barr Virus Serostatus on the Incidence of Graft-Versus-Host Disease in Patients With Acute Leukemia After Hematopoietic Stem-Cell Transplantation: A Study From the Acute Leukemia and Infectious Diseases Working Parties of the Association of Country-Specific Socioeconomic Factors With Survival of Patients Who Experience Severe Classic Acute Graft-vs.-Host Disease After Allogeneic Hematopoietic Cell Transplantation. An Analysis From the Transplant Complications Working Par

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software